Blankenberge, Belgium Clinical Trials

A listing of Blankenberge, Belgium clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 132 clinical trials
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168)

Primary Objective: To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated relapse rate (ARR) in participants with relapsing forms of MS Secondary Objective: To assess efficacy of SAR442168 compared to teriflunomide (Aubagio) on disability progression, MRI lesions, cognitive performance …

teriflunomide
pregnancy test urine
brain lesion
hmr1726
aubagio
Investigational Site Number 0560005
 (9.0 away) Contact site
  • 10 views
  • 13 Jun, 2021
  • +97 other locations
Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of a dual antiplatelet therapy (acetylsalicylic acid +/- clopidogrel) in patients following a recent heart attack …

antiplatelet therapy
clot
aspirin
angiography
troponin
AZ St-Jan Brugge Oostende AV
 (6.4 away) Contact site
  • 57 views
  • 09 Jun, 2021
  • +192 other locations
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy" medicine which does not contain any study medicine) - which treatment participants get is decided by an equal chance. The study will …

Novo Nordisk Investigational Site
 (6.4 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +70 other locations
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evaluate the efficacy and safety of CC- 93538 in adult and adolescent participants with eosinophilic esophagitis (EoE). The study will incorporate a 24-week Induction Phase followed by a 24-week Maintenance Phase. Participants will be …

AZ Sint-Lucas Brugge
 (9.0 away) Contact site
  • 0 views
  • 02 May, 2021
  • +200 other locations
Role of Leukocyte- and Platelet-Rich Fibrin Membranes in Endoscopic Endonasal Skull Base Reconstruction

Prospective investigation of the effectivity of L-PRF membranes for skull base reconstruction after endoscopic endonasal skull base surgery (transsphenoidal) versus classical closure techniques.

AZ Sint-Jan
 (6.4 away) Contact site
  • 0 views
  • 22 Jan, 2021
  • +2 other locations
Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade

The SPARTACUS study will explore the therapeutic efficacy of 2 different treatment strategies for patients suffering from peripheral Spondyloarthritis (pSpA), classified according to the "Assessment in SpondyloArthritis international Society" (ASAS) classification criteria; it will be set up as a 48-week, prospective, randomized, active-comparator controlled, double-blind, double-dummy, clinical trial with a …

AZ Sint-Jan
 (6.4 away) Contact site
  • 0 views
  • 24 Feb, 2021
  • +5 other locations
Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes

Multi-centric open-label randomized controlled trial (RCT) with 10 Belgian centers in pregnant women with type 1 diabetes to assess safety, efficacy, feasibility and cost-effectiveness of 780 MiniMed Medtronic hybrid closed-loop insulin system (intervention group) compared to standard of care therapy (control group).

AZ St Jan Brugge
 (8.1 away) Contact site
  • 0 views
  • 24 Mar, 2021
  • +9 other locations
Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

Biologics, such as brodalumab, are currently the most effective treatment option for patients with moderate-to-severe psoriasis. But they are costly for health care systems and prescribed according to a 'one dose fits all' dosing regimen, leading to potential over- and undertreatment. Within this study we aim to investigate the predictive …

brodalumab
psoriasis
biologics
AZ Sint-Jan
 (6.4 away) Contact site
  • 5 views
  • 24 Jan, 2021
  • +5 other locations
Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Biologics such as secukinumab are currently the most effective treatment option for patients with moderate to severe psoriasis. But they are costly for healthcare systems and still described according to a'one dose fits all' dosing regimen, leading to potential over-and undertreatment. In this study we aim to investigate the predictive …

psoriasis
biologics
AZ Sint-Jan
 (6.4 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +6 other locations
Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

Biologic such as guselkumab are currently the most effective treatment option for patients with moderate to severe psoriasis. But they are costly for healthcare systems and still described according to a 'one dose fits all' dosing regimen, leading to potential over- and undertreatment. In this study we aim to investigate …

psoriasis
AZ Sint-Jan
 (6.4 away) Contact site
  • 1 views
  • 24 Jan, 2021
  • +5 other locations